UnitedHealth Group (UNH) Given New $270.00 Price Target at Argus

UnitedHealth Group (NYSE:UNH) had its price target raised by Argus to $270.00 in a report issued on Thursday. The brokerage currently has a buy rating on the healthcare conglomerate’s stock.

A number of other research firms have also recently issued reports on UNH. Zacks Investment Research cut shares of UnitedHealth Group from a buy rating to a hold rating in a research report on Tuesday, October 10th. Cantor Fitzgerald reiterated a buy rating and set a $225.00 price objective on shares of UnitedHealth Group in a research report on Monday, November 27th. ValuEngine cut shares of UnitedHealth Group from a buy rating to a hold rating in a research report on Thursday, October 5th. Piper Jaffray Companies upped their price objective on shares of UnitedHealth Group to $228.00 and gave the stock an overweight rating in a research report on Tuesday, October 17th. Finally, Jefferies Group reiterated a buy rating and set a $248.00 price objective on shares of UnitedHealth Group in a research report on Friday, December 1st. Two research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. UnitedHealth Group presently has a consensus rating of Buy and an average target price of $243.22.

Shares of UnitedHealth Group (NYSE:UNH) opened at $243.35 on Thursday. UnitedHealth Group has a twelve month low of $156.49 and a twelve month high of $244.35. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58. The firm has a market cap of $235,290.00, a P/E ratio of 22.72, a PEG ratio of 1.42 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.50 by $0.09. The company had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The firm’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.11 EPS. research analysts forecast that UnitedHealth Group will post 12.52 earnings per share for the current year.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 457 shares of the company’s stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total value of $96,440.71. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the completion of the transaction, the director now owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 33,655 shares of company stock valued at $7,469,083. Corporate insiders own 0.89% of the company’s stock.

Large investors have recently bought and sold shares of the company. Blue Chip Partners Inc. bought a new stake in shares of UnitedHealth Group in the 2nd quarter valued at $110,000. Bruderman Asset Management LLC bought a new stake in shares of UnitedHealth Group in the 2nd quarter valued at $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its stake in shares of UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares during the last quarter. BDO Wealth Advisors LLC bought a new stake in shares of UnitedHealth Group in the 2nd quarter valued at $121,000. Finally, Acrospire Investment Management LLC boosted its stake in shares of UnitedHealth Group by 130.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after purchasing an additional 400 shares during the last quarter. 86.09% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece on another site, it was stolen and republished in violation of international trademark and copyright law. The original version of this piece can be viewed at https://www.com-unik.info/2018/01/22/unitedhealth-group-unh-given-new-270-00-price-target-at-argus.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit